EXHIBIT 107
Calculation of Filing Fee Table
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
(Form Type)
Lexaria Bioscience Corp.
(Exact Name of Registrant As Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock | 457(c) and (h) | 707,715(2) | $ | 2.12(3) | $ | 1,500,355.80 |
|
|
| 0.0001531 |
|
| 229.71 | |||||||||||||
Fees Previously Paid | - | - | - | - | - | - | - | |||||||||||||||||||||
Total Offering Amounts | $ | 1,500,355.80 | - | $ | 229.71 | |||||||||||||||||||||||
Total Fees Previously Paid | $ | - | - | $ | - | |||||||||||||||||||||||
Total Fee Offsets | - | - | $ | - | ||||||||||||||||||||||||
Net Fees Due | $ | - | - | $ | 229.71 | |||||||||||||||||||||||
(1) | Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions. | |
|
| |
(2) | Represents shares of common stock reserved for future issuance under the Company’s Equity Incentive Plan, as amended. | |
|
| |
(3) | Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per share of common stock as reported on the Nasdaq Capital Market on December 31, 2024, as reported on the Nasdaq Capital Market | |
